Following 15-day Paxlovid Regimen, Long COVID Benefits Absent

In COVID-19, Latest News by Precision Vaccinations

Stanford Medicine researchers recently reported that an often-prescribed medication for treating COVID-19 did not produce measurable benefits for those suffering from Long COVID.
This disappointing news affects millions of people who are taking Pfizer Inc. Paxlovid™ to combat Long COVID.
A survey by the Agency for Healthcare Research and Quality recently concluded almost 18 million adults have ever had Long COVID.

Read More